| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2012-09-06 15:16:50 UTC |
|---|
| Update Date | 2022-03-07 02:51:45 UTC |
|---|
| HMDB ID | HMDB0014848 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | Ibandronate |
|---|
| Description | Ibandronate, also known as ibandronic acid or R484, belongs to the class of organic compounds known as bisphosphonates. These are organic compounds containing two phosphonate groups linked together through a carbon atoms. Ibandronate is a drug which is used for the treatment and prevention of osteoporosis in postmenopausal women. Ibandronate is a very strong basic compound (based on its pKa). In humans, ibandronate is involved in ibandronate action pathway. Ibandronate is indicated for the treatment and prevention of osteoporosis in post-menopausal women. Ibandronate is a potentially toxic compound. Ibandronic acid or ibandronate sodium is a bisphosphonate medication used in the prevention and treatment of osteoporosis and metastasis-associated skeletal fractures in people with cancer. In May 2003, the U.S. Food and Drug Administration (FDA) approved Ibandronate as a daily treatment for post-menopausal osteoporosis. Every participant also received daily oral doses of calcium and 400IUs [international units] of vitamin D. At the study's conclusion, both doses significantly reduced the occurrence risk of new vertebral fractures by 50–52 percent when compared to the effects of the placebo drug. In 2008, the U.S Food and Drug Administration (FDA) issued a communication warning of the possibility of severe and sometimes incapacitating bone, joint or muscle pain. The basis for this approval was a three-year, randomized, double-blind, placebo-controlled trial women with post-menopausal osteoporosis. A study conducted by the American Society of Bone and Mineral Research concluded that long-term use of bisphosphonates, including Boniva, may increase the risk of a rare but serious fracture of the femur. It was patented in 1986 by Boehringer Mannheim and approved for medical use in 1996. Ibandronic acid is marketed under the trade names Boniva in the USA, Bondronat in Europe, Bonviva in Asia, Bandrone in India, Ibandrix in Ecuador, Adronil in Pakistan, Bondrova in Bangladesh and Bonprove in Egypt. Ibandronate is efficacious for the prevention of metastasis-related bone fractures in multiple myeloma, breast cancer, and certain other cancers. It may also be used to treat hypercalcemia (elevated blood calcium levels). The drug also has been associated with osteonecrosis of the jaw, relatively rare but serious condition. |
|---|
| Structure | CCCCCN(C)CCC(O)(P(O)(O)=O)P(O)(O)=O InChI=1S/C9H23NO7P2/c1-3-4-5-7-10(2)8-6-9(11,18(12,13)14)19(15,16)17/h11H,3-8H2,1-2H3,(H2,12,13,14)(H2,15,16,17) |
|---|
| Synonyms | | Value | Source |
|---|
| Ibandronic acid | Generator | | Bondronat | HMDB | | Ibandronate sodium monohydrate | HMDB | | R484 | HMDB | | (1-Hydroxy-3-(methylpentylamino)propylidene)bisphosphonate | HMDB | | 1-Hydroxy-3-(methylpentylamino)propylidenebisphosphonate | HMDB | | Bonviva | HMDB | | Boniva | HMDB | | Ibandronic acid, sodium salt, monohydrate | HMDB | | Ibandronate sodium | HMDB | | Ibandronate sodium anhydrous | HMDB |
|
|---|
| Chemical Formula | C9H23NO7P2 |
|---|
| Average Molecular Weight | 319.2289 |
|---|
| Monoisotopic Molecular Weight | 319.094975119 |
|---|
| IUPAC Name | {1-hydroxy-3-[methyl(pentyl)amino]-1-phosphonopropyl}phosphonic acid |
|---|
| Traditional Name | ibandronate |
|---|
| CAS Registry Number | 114084-78-5 |
|---|
| SMILES | CCCCCN(C)CCC(O)(P(O)(O)=O)P(O)(O)=O |
|---|
| InChI Identifier | InChI=1S/C9H23NO7P2/c1-3-4-5-7-10(2)8-6-9(11,18(12,13)14)19(15,16)17/h11H,3-8H2,1-2H3,(H2,12,13,14)(H2,15,16,17) |
|---|
| InChI Key | MPBVHIBUJCELCL-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as bisphosphonates. These are organic compounds containing two phosphonate groups linked together through a carbon atoms. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organic acids and derivatives |
|---|
| Class | Organic phosphonic acids and derivatives |
|---|
| Sub Class | Bisphosphonates |
|---|
| Direct Parent | Bisphosphonates |
|---|
| Alternative Parents | |
|---|
| Substituents | - Bisphosphonate
- Organophosphonic acid
- 1,3-aminoalcohol
- Tertiary aliphatic amine
- Tertiary amine
- Organic nitrogen compound
- Organic oxygen compound
- Organopnictogen compound
- Organic oxide
- Hydrocarbon derivative
- Organophosphorus compound
- Organooxygen compound
- Organonitrogen compound
- Amine
- Aliphatic acyclic compound
|
|---|
| Molecular Framework | Aliphatic acyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | 13.4 g/L | Not Available | | LogP | -2.1 | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 2.11 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 10.6206 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 8.83 minutes | 32390414 | | AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid | 526.0 seconds | 40023050 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 380.6 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 243.2 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 62.9 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 177.5 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 71.8 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 318.1 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 268.9 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 1017.4 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 603.2 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 48.3 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 486.9 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 162.2 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 241.3 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 1062.4 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 727.9 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 408.7 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| Ibandronate,1TMS,isomer #1 | CCCCCN(C)CCC(O[Si](C)(C)C)(P(=O)(O)O)P(=O)(O)O | 2452.7 | Semi standard non polar | 33892256 | | Ibandronate,1TMS,isomer #2 | CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O[Si](C)(C)C | 2434.6 | Semi standard non polar | 33892256 | | Ibandronate,2TMS,isomer #1 | CCCCCN(C)CCC(O[Si](C)(C)C)(P(=O)(O)O)P(=O)(O)O[Si](C)(C)C | 2429.4 | Semi standard non polar | 33892256 | | Ibandronate,2TMS,isomer #1 | CCCCCN(C)CCC(O[Si](C)(C)C)(P(=O)(O)O)P(=O)(O)O[Si](C)(C)C | 2228.7 | Standard non polar | 33892256 | | Ibandronate,2TMS,isomer #1 | CCCCCN(C)CCC(O[Si](C)(C)C)(P(=O)(O)O)P(=O)(O)O[Si](C)(C)C | 3247.4 | Standard polar | 33892256 | | Ibandronate,2TMS,isomer #2 | CCCCCN(C)CCC(O)(P(=O)(O)O[Si](C)(C)C)P(=O)(O)O[Si](C)(C)C | 2390.7 | Semi standard non polar | 33892256 | | Ibandronate,2TMS,isomer #2 | CCCCCN(C)CCC(O)(P(=O)(O)O[Si](C)(C)C)P(=O)(O)O[Si](C)(C)C | 2282.8 | Standard non polar | 33892256 | | Ibandronate,2TMS,isomer #2 | CCCCCN(C)CCC(O)(P(=O)(O)O[Si](C)(C)C)P(=O)(O)O[Si](C)(C)C | 3183.5 | Standard polar | 33892256 | | Ibandronate,2TMS,isomer #3 | CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O[Si](C)(C)C)O[Si](C)(C)C | 2429.4 | Semi standard non polar | 33892256 | | Ibandronate,2TMS,isomer #3 | CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O[Si](C)(C)C)O[Si](C)(C)C | 2284.2 | Standard non polar | 33892256 | | Ibandronate,2TMS,isomer #3 | CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O[Si](C)(C)C)O[Si](C)(C)C | 3128.5 | Standard polar | 33892256 | | Ibandronate,3TMS,isomer #1 | CCCCCN(C)CCC(O[Si](C)(C)C)(P(=O)(O)O[Si](C)(C)C)P(=O)(O)O[Si](C)(C)C | 2427.7 | Semi standard non polar | 33892256 | | Ibandronate,3TMS,isomer #1 | CCCCCN(C)CCC(O[Si](C)(C)C)(P(=O)(O)O[Si](C)(C)C)P(=O)(O)O[Si](C)(C)C | 2273.9 | Standard non polar | 33892256 | | Ibandronate,3TMS,isomer #1 | CCCCCN(C)CCC(O[Si](C)(C)C)(P(=O)(O)O[Si](C)(C)C)P(=O)(O)O[Si](C)(C)C | 2985.5 | Standard polar | 33892256 | | Ibandronate,3TMS,isomer #2 | CCCCCN(C)CCC(O[Si](C)(C)C)(P(=O)(O)O)P(=O)(O[Si](C)(C)C)O[Si](C)(C)C | 2457.4 | Semi standard non polar | 33892256 | | Ibandronate,3TMS,isomer #2 | CCCCCN(C)CCC(O[Si](C)(C)C)(P(=O)(O)O)P(=O)(O[Si](C)(C)C)O[Si](C)(C)C | 2301.1 | Standard non polar | 33892256 | | Ibandronate,3TMS,isomer #2 | CCCCCN(C)CCC(O[Si](C)(C)C)(P(=O)(O)O)P(=O)(O[Si](C)(C)C)O[Si](C)(C)C | 2934.5 | Standard polar | 33892256 | | Ibandronate,3TMS,isomer #3 | CCCCCN(C)CCC(O)(P(=O)(O)O[Si](C)(C)C)P(=O)(O[Si](C)(C)C)O[Si](C)(C)C | 2398.4 | Semi standard non polar | 33892256 | | Ibandronate,3TMS,isomer #3 | CCCCCN(C)CCC(O)(P(=O)(O)O[Si](C)(C)C)P(=O)(O[Si](C)(C)C)O[Si](C)(C)C | 2330.6 | Standard non polar | 33892256 | | Ibandronate,3TMS,isomer #3 | CCCCCN(C)CCC(O)(P(=O)(O)O[Si](C)(C)C)P(=O)(O[Si](C)(C)C)O[Si](C)(C)C | 2936.3 | Standard polar | 33892256 | | Ibandronate,4TMS,isomer #1 | CCCCCN(C)CCC(O[Si](C)(C)C)(P(=O)(O)O[Si](C)(C)C)P(=O)(O[Si](C)(C)C)O[Si](C)(C)C | 2469.5 | Semi standard non polar | 33892256 | | Ibandronate,4TMS,isomer #1 | CCCCCN(C)CCC(O[Si](C)(C)C)(P(=O)(O)O[Si](C)(C)C)P(=O)(O[Si](C)(C)C)O[Si](C)(C)C | 2362.5 | Standard non polar | 33892256 | | Ibandronate,4TMS,isomer #1 | CCCCCN(C)CCC(O[Si](C)(C)C)(P(=O)(O)O[Si](C)(C)C)P(=O)(O[Si](C)(C)C)O[Si](C)(C)C | 2744.6 | Standard polar | 33892256 | | Ibandronate,4TMS,isomer #2 | CCCCCN(C)CCC(O)(P(=O)(O[Si](C)(C)C)O[Si](C)(C)C)P(=O)(O[Si](C)(C)C)O[Si](C)(C)C | 2409.8 | Semi standard non polar | 33892256 | | Ibandronate,4TMS,isomer #2 | CCCCCN(C)CCC(O)(P(=O)(O[Si](C)(C)C)O[Si](C)(C)C)P(=O)(O[Si](C)(C)C)O[Si](C)(C)C | 2384.6 | Standard non polar | 33892256 | | Ibandronate,4TMS,isomer #2 | CCCCCN(C)CCC(O)(P(=O)(O[Si](C)(C)C)O[Si](C)(C)C)P(=O)(O[Si](C)(C)C)O[Si](C)(C)C | 2720.3 | Standard polar | 33892256 | | Ibandronate,5TMS,isomer #1 | CCCCCN(C)CCC(O[Si](C)(C)C)(P(=O)(O[Si](C)(C)C)O[Si](C)(C)C)P(=O)(O[Si](C)(C)C)O[Si](C)(C)C | 2494.1 | Semi standard non polar | 33892256 | | Ibandronate,5TMS,isomer #1 | CCCCCN(C)CCC(O[Si](C)(C)C)(P(=O)(O[Si](C)(C)C)O[Si](C)(C)C)P(=O)(O[Si](C)(C)C)O[Si](C)(C)C | 2454.5 | Standard non polar | 33892256 | | Ibandronate,5TMS,isomer #1 | CCCCCN(C)CCC(O[Si](C)(C)C)(P(=O)(O[Si](C)(C)C)O[Si](C)(C)C)P(=O)(O[Si](C)(C)C)O[Si](C)(C)C | 2548.1 | Standard polar | 33892256 | | Ibandronate,1TBDMS,isomer #1 | CCCCCN(C)CCC(O[Si](C)(C)C(C)(C)C)(P(=O)(O)O)P(=O)(O)O | 2709.8 | Semi standard non polar | 33892256 | | Ibandronate,1TBDMS,isomer #2 | CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O[Si](C)(C)C(C)(C)C | 2692.1 | Semi standard non polar | 33892256 | | Ibandronate,2TBDMS,isomer #1 | CCCCCN(C)CCC(O[Si](C)(C)C(C)(C)C)(P(=O)(O)O)P(=O)(O)O[Si](C)(C)C(C)(C)C | 2931.6 | Semi standard non polar | 33892256 | | Ibandronate,2TBDMS,isomer #1 | CCCCCN(C)CCC(O[Si](C)(C)C(C)(C)C)(P(=O)(O)O)P(=O)(O)O[Si](C)(C)C(C)(C)C | 2607.3 | Standard non polar | 33892256 | | Ibandronate,2TBDMS,isomer #1 | CCCCCN(C)CCC(O[Si](C)(C)C(C)(C)C)(P(=O)(O)O)P(=O)(O)O[Si](C)(C)C(C)(C)C | 3448.0 | Standard polar | 33892256 | | Ibandronate,2TBDMS,isomer #2 | CCCCCN(C)CCC(O)(P(=O)(O)O[Si](C)(C)C(C)(C)C)P(=O)(O)O[Si](C)(C)C(C)(C)C | 2882.2 | Semi standard non polar | 33892256 | | Ibandronate,2TBDMS,isomer #2 | CCCCCN(C)CCC(O)(P(=O)(O)O[Si](C)(C)C(C)(C)C)P(=O)(O)O[Si](C)(C)C(C)(C)C | 2660.3 | Standard non polar | 33892256 | | Ibandronate,2TBDMS,isomer #2 | CCCCCN(C)CCC(O)(P(=O)(O)O[Si](C)(C)C(C)(C)C)P(=O)(O)O[Si](C)(C)C(C)(C)C | 3427.6 | Standard polar | 33892256 | | Ibandronate,2TBDMS,isomer #3 | CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C | 2928.4 | Semi standard non polar | 33892256 | | Ibandronate,2TBDMS,isomer #3 | CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C | 2639.3 | Standard non polar | 33892256 | | Ibandronate,2TBDMS,isomer #3 | CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C | 3389.2 | Standard polar | 33892256 | | Ibandronate,3TBDMS,isomer #1 | CCCCCN(C)CCC(O[Si](C)(C)C(C)(C)C)(P(=O)(O)O[Si](C)(C)C(C)(C)C)P(=O)(O)O[Si](C)(C)C(C)(C)C | 3127.5 | Semi standard non polar | 33892256 | | Ibandronate,3TBDMS,isomer #1 | CCCCCN(C)CCC(O[Si](C)(C)C(C)(C)C)(P(=O)(O)O[Si](C)(C)C(C)(C)C)P(=O)(O)O[Si](C)(C)C(C)(C)C | 2772.9 | Standard non polar | 33892256 | | Ibandronate,3TBDMS,isomer #1 | CCCCCN(C)CCC(O[Si](C)(C)C(C)(C)C)(P(=O)(O)O[Si](C)(C)C(C)(C)C)P(=O)(O)O[Si](C)(C)C(C)(C)C | 3255.1 | Standard polar | 33892256 | | Ibandronate,3TBDMS,isomer #2 | CCCCCN(C)CCC(O[Si](C)(C)C(C)(C)C)(P(=O)(O)O)P(=O)(O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C | 3157.5 | Semi standard non polar | 33892256 | | Ibandronate,3TBDMS,isomer #2 | CCCCCN(C)CCC(O[Si](C)(C)C(C)(C)C)(P(=O)(O)O)P(=O)(O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C | 2778.9 | Standard non polar | 33892256 | | Ibandronate,3TBDMS,isomer #2 | CCCCCN(C)CCC(O[Si](C)(C)C(C)(C)C)(P(=O)(O)O)P(=O)(O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C | 3205.6 | Standard polar | 33892256 | | Ibandronate,3TBDMS,isomer #3 | CCCCCN(C)CCC(O)(P(=O)(O)O[Si](C)(C)C(C)(C)C)P(=O)(O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C | 3090.6 | Semi standard non polar | 33892256 | | Ibandronate,3TBDMS,isomer #3 | CCCCCN(C)CCC(O)(P(=O)(O)O[Si](C)(C)C(C)(C)C)P(=O)(O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C | 2802.3 | Standard non polar | 33892256 | | Ibandronate,3TBDMS,isomer #3 | CCCCCN(C)CCC(O)(P(=O)(O)O[Si](C)(C)C(C)(C)C)P(=O)(O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C | 3225.2 | Standard polar | 33892256 | | Ibandronate,4TBDMS,isomer #1 | CCCCCN(C)CCC(O[Si](C)(C)C(C)(C)C)(P(=O)(O)O[Si](C)(C)C(C)(C)C)P(=O)(O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C | 3337.0 | Semi standard non polar | 33892256 | | Ibandronate,4TBDMS,isomer #1 | CCCCCN(C)CCC(O[Si](C)(C)C(C)(C)C)(P(=O)(O)O[Si](C)(C)C(C)(C)C)P(=O)(O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C | 2952.2 | Standard non polar | 33892256 | | Ibandronate,4TBDMS,isomer #1 | CCCCCN(C)CCC(O[Si](C)(C)C(C)(C)C)(P(=O)(O)O[Si](C)(C)C(C)(C)C)P(=O)(O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C | 3085.8 | Standard polar | 33892256 | | Ibandronate,4TBDMS,isomer #2 | CCCCCN(C)CCC(O)(P(=O)(O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)P(=O)(O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C | 3283.3 | Semi standard non polar | 33892256 | | Ibandronate,4TBDMS,isomer #2 | CCCCCN(C)CCC(O)(P(=O)(O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)P(=O)(O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C | 2951.1 | Standard non polar | 33892256 | | Ibandronate,4TBDMS,isomer #2 | CCCCCN(C)CCC(O)(P(=O)(O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)P(=O)(O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C | 3068.6 | Standard polar | 33892256 | | Ibandronate,5TBDMS,isomer #1 | CCCCCN(C)CCC(O[Si](C)(C)C(C)(C)C)(P(=O)(O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)P(=O)(O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C | 3509.0 | Semi standard non polar | 33892256 | | Ibandronate,5TBDMS,isomer #1 | CCCCCN(C)CCC(O[Si](C)(C)C(C)(C)C)(P(=O)(O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)P(=O)(O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C | 3154.7 | Standard non polar | 33892256 | | Ibandronate,5TBDMS,isomer #1 | CCCCCN(C)CCC(O[Si](C)(C)C(C)(C)C)(P(=O)(O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)P(=O)(O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C | 2995.5 | Standard polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - Ibandronate GC-MS (Non-derivatized) - 70eV, Positive | splash10-08gl-9130000000-f1a145132fe5a1d4852e | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Ibandronate GC-MS (1 TMS) - 70eV, Positive | splash10-0233-9113000000-5576d5d18472e7b11a4a | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Ibandronate GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ibandronate 10V, Positive-QTOF | splash10-00di-1089000000-b2afb60f04d1d7076014 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ibandronate 20V, Positive-QTOF | splash10-0080-7790000000-037f20f19b338e3a638b | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ibandronate 40V, Positive-QTOF | splash10-01c3-9120000000-6b11acb03cc3d07ff611 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ibandronate 10V, Negative-QTOF | splash10-014r-1159000000-86d2ef11326a8e83cda4 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ibandronate 20V, Negative-QTOF | splash10-0udr-4694000000-cd166d728f1d865e6ce5 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ibandronate 40V, Negative-QTOF | splash10-003r-9000000000-d06bd55271aea4ebdb18 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ibandronate 10V, Positive-QTOF | splash10-00di-1009000000-81303b095a47932563f4 | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ibandronate 20V, Positive-QTOF | splash10-00di-0019000000-df5f634d806e75d58992 | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ibandronate 40V, Positive-QTOF | splash10-0597-9100000000-98c63a25e8164e665af3 | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ibandronate 10V, Negative-QTOF | splash10-014i-0009000000-2f3bcd85bd99ea1851c6 | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ibandronate 20V, Negative-QTOF | splash10-0gdi-5009000000-06df6dec77c09a2d386c | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ibandronate 40V, Negative-QTOF | splash10-0fai-9131000000-ba46adab8d9bdbd3c87c | 2021-10-11 | Wishart Lab | View Spectrum |
NMR Spectra| Spectrum Type | Description | Deposition Date | Source | View |
|---|
| Predicted 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum |
|
|---|